Mankind Pharma shares gain 3% on acquiring Rivotril brand rights from Roche (Soban News)

The acquisition is expected to strengthen Mankind Pharma’s presence in the central nervous system (CNS) segment and complement its existing neuro portfolio​The acquisition is expected to strengthen Mankind Pharma’s presence in the central nervous system (CNS) segment and complement its existing neuro portfolio ​Latest News [ SOBAN NEWS: International and National ]